Literature DB >> 8635115

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis.

J P Pignon, L A Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8635115     DOI： 10.1002/(SICI)1097-0142(19960601)77:11<2413::AID-CNCR34>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Outcomes research in cancer clinical trial cooperative groups: the RTOG model.

Authors:  D W Bruner; B Movsas; A Konski; M Roach; M Bondy; C Scarintino; C Scott; W Curran
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

2.  SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013.

Authors:  C Camps; E Felip; R García-Campelo; J M Trigo; P Garrido
Journal:  Clin Transl Oncol       Date:  2013-08-06       Impact factor: 3.405

Review 3.  Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.

Authors:  Richard J Gralla; Ulrich Gatzemeier; Vittorio Gebbia; Rudolf Huber; Mary O'Brien; Christian Puozzo
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Advances in dosimetry and biological predictors of radiation-induced esophagitis.

Authors:  Yang Yu; Hui Guan; Yuanli Dong; Ligang Xing; Xiaolin Li
Journal:  Onco Targets Ther       Date:  2016-01-28       Impact factor: 4.147

5.  Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non-small cell lung cancer: Results of a single-arm prospective cohort study.

Authors:  Ping-Chih Hsu; John Wen-Chang Chang; Chun-Chieh Wang; Chen-Te Wu; Yu-Ching Lin; Chih-Liang Wang; Tin-Yu Lin; Shih-Hong Li; Yi-Chen Wu; Scott Chih-Hsi Kuo; Cheng-Ta Yang; Chien-Ying Liu; Chih-Hung Chen
Journal:  Thorac Cancer       Date:  2019-07-05       Impact factor: 3.500

6.  Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy.

Authors:  Farkhad Manapov; Susanna Sepe; Maximilian Niyazi; Claus Belka; Godehard Friedel; Wilfried Budach
Journal:  Radiat Oncol       Date:  2013-05-17       Impact factor: 3.481

7.  Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Authors:  Yuchun Wei; Xueting Qin; Xiaoli Liu; Jinsong Zheng; Xiaohui Luan; Yue Zhou; Jinming Yu; Shuanghu Yuan
Journal:  J Transl Med       Date:  2022-02-02       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.